Creative Medical Technology Holdings Announces Patent filing based on Preclinical Data in Model of Heart Attack using ImmCelz® Regenerative Immunotherapy ...Middle East

News by : (PR Newswire) -
PHOENIX, Dec. 31, 2020 /PRNewswire/ -- (OTC – CELZ) Creative Medical Technology Holdings Inc. announced today positive preclinical data using ImmCelz® in treatment of a model of heart attack. Patent application #63/132472, entitled "Treatment of Heart Failure and/or Post Infarct...

Hence then, the article about creative medical technology holdings announces patent filing based on preclinical data in model of heart attack using immcelz regenerative immunotherapy was published today ( ) and is available on PR Newswire ( Middle East ) The editorial team at PressBee has edited and verified it, and it may have been modified, fully republished, or quoted. You can read and follow the updates of this news or article from its original source.

Read More Details
Finally We wish PressBee provided you with enough information of ( Creative Medical Technology Holdings Announces Patent filing based on Preclinical Data in Model of Heart Attack using ImmCelz® Regenerative Immunotherapy )

Last updated :

Also on site :

Most Viewed News
جديد الاخبار